Across TCGA pan-cancer cohorts, RPS26P15 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RPS26P15’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RPS26P15 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPS26P15 is over-expressed in tumor.

KIRC, LIHC, and LUAD are the cancer types where RPS26P15 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS26P15 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	II,III,IV	+0.298	<.001	10	view →
LIHC	All	All	+0.128	.011	3	view →
LUAD	Female	All	+0.366	.039	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: RPS26P15 RNA expression & survival · all RPS26P15 data types